LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection

PLoS Pathogens

Volumn 12, Issue 9, 2016, Pages

  Toth, Zsolt ^a,b   Papp, Bernadett ^a,b   Brulois, Kevin ^a   Choi, Youn Jung ^a   Gao, Shou Jiang ^a   Jung, Jae U ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR EZH2; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; VIRUS ANTIGEN;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; DNA BINDING; DNA MICROARRAY; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NONHUMAN; VIRUS GENOME; VIRUS INFECTION; GENE SILENCING; GENETICS; HERPES VIRUS INFECTION; METABOLISM; PATHOLOGY; PLASMID; PROMOTER REGION;

ANTIGENS, VIRAL; GENE KNOCKDOWN TECHNIQUES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; PLASMIDS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC;

EID: 84989941453     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005878     Document Type: Article

References (58)

1. McLaughlin-Drubin ME, Munger K, (2008) Viruses associated with human cancer. Biochim Biophys Acta1782: 127–150. doi: 10.1016/j.bbadis.2007.12.00518201576
2. Dittmer DP, Damania B, (2013) Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)—an update. Current opinion in virology3: 238–244. doi: 10.1016/j.coviro.2013.05.01223769237
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science266: 1865–1869. 7997879
4. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A93: 14862–14867. 8962146
5. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol72: 8309–8315. 9733875
6. Staudt MR, Dittmer DP, (2003) Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma. Current drug targets Infectious disorders3: 129–135. 12769790
7. Sin SH, Dittmer DP, (2013) Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. Blood121: 2952–2963. doi: 10.1182/blood-2012-03-41562023365457
8. Hu J, Garber AC, Renne R, (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol76: 11677–11687. 12388727
9. Ballestas ME, Chatis PA, Kaye KM, (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science284: 641–644. 10213686
10. Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES, (2014) KSHV LANA—the master regulator of KSHV latency. Viruses6: 4961–4998. doi: 10.3390/v612496125514370
11. Gunther T, Schreiner S, Dobner T, Tessmer U, Grundhoff A, (2014) Influence of ND10 components on epigenetic determinants of early KSHV latency establishment. PLoS Pathog10: e1004274. doi: 10.1371/journal.ppat.100427425033267
12. Toth Z, Brulois K, Lee HR, Izumiya Y, Tepper C, et al. (2013) Biphasic Euchromatin-to-Heterochromatin Transition on the KSHV Genome Following De Novo Infection. PLoS Pathog9: e1003813. doi: 10.1371/journal.ppat.100381324367262
13. Jha HC, Lu J, Verma SC, Banerjee S, Mehta D, et al. (2014) Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells. mBio5.
14. Toth Z, Brulois K, Jung JU, (2013) The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses5: 1346–1373. doi: 10.3390/v505134623698402
15. Renne R, Lagunoff M, Zhong W, Ganem D, (1996) The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol70: 8151–8154. 8892944
16. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, et al. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog6: e1001013. doi: 10.1371/journal.ppat.100101320661424
17. Gunther T, Grundhoff A, (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog6: e1000935. doi: 10.1371/journal.ppat.100093520532208
18. Stedman W, Deng Z, Lu F, Lieberman PM, (2004) ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol78: 12566–12575. 15507644
19. Chang PC, Fitzgerald LD, Hsia DA, Izumiya Y, Wu CY, et al. (2011) Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor. J Virol85: 3283–3293. doi: 10.1128/JVI.02485-1021228229
20. Simon JA, Kingston RE, (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nature reviews Molecular cell biology10: 697–708. doi: 10.1038/nrm276319738629
21. Margueron R, Reinberg D, (2011) The Polycomb complex PRC2 and its mark in life. Nature469: 343–349. doi: 10.1038/nature0978421248841
22. Nazer E, Lei EP, (2014) Modulation of chromatin modifying complexes by noncoding RNAs in trans. Current opinion in genetics & development25: 68–73.
23. Li Q, Zhou F, Ye F, Gao SJ, (2008) Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology379: 234–244. doi: 10.1016/j.virol.2008.06.04318684478
24. Lu F, Day L, Gao SJ, Lieberman PM, (2006) Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J Virol80: 5273–5282. 16699007
25. Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, et al. (2012) Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J Virol86: 5752–5762. doi: 10.1128/JVI.07216-1122419807
26. An FQ, Compitello N, Horwitz E, Sramkoski M, Knudsen ES, et al. (2005) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem280: 3862–3874. 15525642
27. Ballestas ME, Kaye KM, (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future microbiology6: 1399–1413. doi: 10.2217/fmb.11.13722122438
28. Kelley-Clarke B, Ballestas ME, Srinivasan V, Barbera AJ, Komatsu T, et al. (2007) Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J Virol81: 4348–4356. 17287261
29. Brockdorff N, (2011) Chromosome silencing mechanisms in X-chromosome inactivation: unknown unknowns. Development138: 5057–5065. doi: 10.1242/dev.06527622069184
30. Hellert J, Weidner-Glunde M, Krausze J, Lunsdorf H, Ritter C, et al. (2015) The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA. Proc Natl Acad Sci U S A112: 6694–6699. doi: 10.1073/pnas.142180411225947153
31. Domsic JF, Chen HS, Lu F, Marmorstein R, Lieberman PM, (2013) Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog9: e1003672. doi: 10.1371/journal.ppat.100367224146617
32. Correia B, Cerqueira SA, Beauchemin C, Pires de Miranda M, Li S, et al. (2013) Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency. PLoS Pathog9: e1003673. doi: 10.1371/journal.ppat.100367324146618
33. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, et al. (2006) The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science311: 856–861. 16469929
34. Verma SC, Choudhuri T, Kaul R, Robertson ES, (2006) Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol80: 2243–2256. 16474132
35. Hu J, Yang Y, Turner PC, Jain V, McIntyre LM, et al. (2014) LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex. PLoS Pathog10: e1004240. doi: 10.1371/journal.ppat.100424025033463
36. Mercier A, Arias C, Madrid AS, Holdorf MM, Ganem D, (2014) Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. J Virol88: 6762–6777. doi: 10.1128/JVI.00268-1424696474
37. Campbell M, Chang PC, Huerta S, Izumiya C, Davis R, et al. (2012) Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen. J Biol Chem287: 5806–5818. doi: 10.1074/jbc.M111.28949622179613
38. Kim KY, Huerta SB, Izumiya C, Wang DH, Martinez A, et al. (2013) Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. J Virol87: 6782–6793. doi: 10.1128/JVI.00011-1323576503
39. Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD, (2002) Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol76: 11596–11604. 12388720
40. You J, Srinivasan V, Denis GV, Harrington WJ, Jr.Ballestas ME, et al. (2006) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol80: 8909–8919. 16940503
41. Lim C, Lee D, Seo T, Choi C, Choe J, (2003) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem278: 7397–7405. 12486118
42. Viejo-Borbolla A, Ottinger M, Bruning E, Burger A, Konig R, et al. (2005) Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol79: 13618–13629. 16227282
43. Hellert J, Weidner-Glunde M, Krausze J, Richter U, Adler H, et al. (2013) A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins. PLoS Pathog9: e1003640. doi: 10.1371/journal.ppat.100364024146614
44. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, et al. (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature449: 731–734. 17713478
45. Tie F, Banerjee R, Saiakhova AR, Howard B, Monteith KE, et al. (2014) Trithorax monomethylates histone H3K4 and interacts directly with CBP to promote H3K27 acetylation and antagonize Polycomb silencing. Development141: 1129–1139. doi: 10.1242/dev.10239224550119
46. Zhang T, Cooper S, Brockdorff N, (2015) The interplay of histone modifications—writers that read. EMBO Rep16: 1467–1481. doi: 10.15252/embr.20154094526474904
47. Stuber G, Mattsson K, Flaberg E, Kati E, Markasz L, et al. (2007) HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol Cancer6: 28. 17433107
48. Viejo-Borbolla A, Kati E, Sheldon JA, Nathan K, Mattsson K, et al. (2003) A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol77: 7093–7100. 12768028
49. Sun R, Liang D, Gao Y, Lan K, (2014) Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency. J Virol88: 7331–7344. doi: 10.1128/JVI.00596-1424741090
50. Krithivas A, Young DB, Liao G, Greene D, Hayward SD, (2000) Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol74: 9637–9645. 11000236
51. Shamay M, Krithivas A, Zhang J, Hayward SD, (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci U S A103: 14554–14559. 16983096
52. Shamay M, Liu J, Li R, Liao G, Shen L, et al. (2012) A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. J Virol86: 5179–5191. doi: 10.1128/JVI.00169-1222379092
53. Lan K, Kuppers DA, Verma SC, Robertson ES, (2004) Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol78: 6585–6594. 15163750
54. Verma SC, Lan K, Choudhuri T, Robertson ES, (2006) Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. J Virol80: 3445–3458. 16537612
55. Myoung J, Ganem D, (2011) Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods174: 12–21. doi: 10.1016/j.jviromet.2011.03.01221419799
56. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, et al. (2012) Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol86: 9708–9720. doi: 10.1128/JVI.01019-1222740391
57. Jain V, Plaisance-Bonstaff K, Sangani R, Lanier C, Dolce A, et al. (2016) A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants. Viruses8.
58. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A102: 15545–15550. 16199517